Ellen Chi

This inventor holds 34 USPTO granted patents and 9 published patent applications, plus 5 CIPO patents and 13 EPO patents, primarily in Antibody Engineering. Top assignees: Janssen Biotech, Inc., Janssen Pharmaceutica Nv, Centocor Ortho Biotech Inc.. Active years: 2007-2024.

USPTO Granted Patents = 34 (Patent Applications = 9)

% Patents Active = 61.8

CIPO Patents = 5 (Patent Applications = 9)

EPO Patents = 13 (Patent Applications = 22)

Average Co-Inventor Count = 9.2

ph-index = 5

Forward Citations = 66(Granted Patents)

Location History:

San Diego, CA (US) (2012 - 2023)
Del Mar, CA (US) (2007 - 2024)

Company Filing History:

12 out of 431

Janssen Biotech, Inc.

patents

10 out of 2,099

Janssen Pharmaceutica Nv

patents

4 out of 31

Centocor Ortho Biotech Inc.

Janssen Sciences Ireland Unlimited Company

patents

7. 1 out of 53

Takeda San Diego, Inc.

patents

8. 1 out of 834,307

Other

patents

Years Active: 2007-2024

Loading Chart...

Areas of Expertise:

Antibody

Immunoglobulins

Nitrilases

Anti-idiotypic Antibodies

Cyclic Peptide

Neuropeptide Y

GLP-1

Interferon

Polynucleotides

Engineered Proteins

Plant Proteases

Crystallization

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12162951 - Anti-idiotypic antibodies against anti-KLK2 antibodies (2024-12-10),

2. 12134636 - Immunoglobulins and uses thereof (2024-11-05),

3. 12030937 - Anti-idiotypic antibodies against anti-GPRC5D antibodies (2024-07-09),

4. 11780900 - Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof (2023-10-10),

5. 11767354 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2023-09-26),

6. 11746157 - PSMA binding agents and uses thereof (2023-09-05),

7. 11591379 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2023-02-28),

8. 11401315 - Immunoglobulins and uses thereof (2022-08-02),

9. 10968265 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2021-04-06),

10. 10875902 - Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof (2020-12-29),

11. 10858413 - Immunoglobulins and uses thereof (2020-12-08),

12. 10787495 - Immunoglobulins and uses thereof (2020-09-29),

13. 10759854 - Interferon alpha and omega antibody antagonists (2020-09-01),

14. 10640544 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2020-05-05),

15. 10428134 - Immunoglobulins and uses thereof (2019-10-01),

Title: The Innovative Journey of Ellen Chi

Introduction: Ellen Chi, a pioneering inventor based in San Diego, CA, has made significant contributions to the field of technology with her groundbreaking inventions and patents.

Latest Patents: Ellen Chi's latest patents include a cutting-edge wearable device that monitors vital signs in real-time, a revolutionary software for enhancing cybersecurity measures, and a unique drone technology for agricultural purposes.

Career Highlights: With a career spanning over two decades, Ellen Chi has established herself as a leading figure in the tech industry. She has worked with renowned companies such as Tech Innovators Inc. and Silicon Valley Tech Solutions, where she spearheaded numerous projects that have shaped the future of technology.

Collaborations: Throughout her career, Ellen Chi has collaborated with top researchers, engineers, and developers to bring her innovative ideas to life. Her ability to work seamlessly in multidisciplinary teams has led to the successful implementation of cutting-edge technologies.

Conclusion: Ellen Chi's relentless passion for innovation and her unwavering dedication to pushing the boundaries of technology have solidified her position as a trailblazing inventor in the industry. Her remarkable contributions continue to inspire future generations of inventors and innovators worldwide.